BFI Co., LLC 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Sep 6, 2018
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Sale
Class A Common Stock
2018-09-06$47.47/sh−600$28,482→ 30,000 total - Conversion
Class A Common Stock
2018-09-05+20,000→ 50,000 total - Sale
Class A Common Stock
2018-09-05$47.30/sh−10,000$473,000→ 40,000 total - Sale
Class A Common Stock
2018-09-06$46.94/sh−9,400$441,236→ 30,600 total - Conversion
Class B Common Stock
2018-09-05−20,000→ 20,196,034 totalExercise: $0.00→ Class A Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.05 to $47.60, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.40, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.45 to $47.50, inclusive.